Ultralife (NASDAQ:ULBI) Director Bradford Whitmore Purchases 14,882 Shares

Ultralife Corporation (NASDAQ:ULBIGet Free Report) Director Bradford Whitmore acquired 14,882 shares of Ultralife stock in a transaction that occurred on Monday, December 15th. The stock was acquired at an average cost of $5.66 per share, with a total value of $84,232.12. Following the completion of the purchase, the director owned 1,207,043 shares in the company, valued at approximately $6,831,863.38. This represents a 1.25% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Ultralife Stock Up 0.7%

NASDAQ:ULBI traded up $0.04 on Tuesday, hitting $5.79. 75,026 shares of the company’s stock traded hands, compared to its average volume of 70,149. The company has a market cap of $96.40 million, a PE ratio of 57.90 and a beta of 0.88. Ultralife Corporation has a 1 year low of $4.07 and a 1 year high of $9.52. The company has a current ratio of 2.99, a quick ratio of 1.42 and a debt-to-equity ratio of 0.34. The firm has a 50-day moving average price of $6.19 and a 200-day moving average price of $7.11.

Ultralife (NASDAQ:ULBIGet Free Report) last posted its quarterly earnings results on Monday, November 17th. The technology company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.21 by ($0.28). Ultralife had a return on equity of 1.66% and a net margin of 0.92%.The company had revenue of $43.37 million for the quarter, compared to analyst estimates of $53.00 million.

Analyst Ratings Changes

ULBI has been the subject of a number of research reports. Wall Street Zen cut Ultralife from a “strong-buy” rating to a “hold” rating in a research report on Saturday, September 13th. Weiss Ratings reissued a “sell (d+)” rating on shares of Ultralife in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Read Our Latest Analysis on ULBI

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. RBF Capital LLC bought a new stake in Ultralife during the second quarter valued at about $2,020,000. Truffle Hound Capital LLC acquired a new position in shares of Ultralife during the 2nd quarter worth about $2,245,000. Nuveen LLC bought a new stake in Ultralife during the 1st quarter valued at approximately $116,000. Janney Montgomery Scott LLC grew its holdings in Ultralife by 1.1% in the 2nd quarter. Janney Montgomery Scott LLC now owns 446,250 shares of the technology company’s stock valued at $4,007,000 after buying an additional 5,000 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new position in shares of Ultralife during the second quarter worth approximately $259,000. 30.68% of the stock is currently owned by institutional investors and hedge funds.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Read More

Insider Buying and Selling by Quarter for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.